Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Number To Know…30,000,000

Executive Summary

$30m is the amount of equity financing raised by Cardiva Medical to fund commercialization of its VASCADE vascular closure system.

Cardiva Medical announced March 14 that it raised $30m in equity funds to expand commercialization of its CE-marked and US FDA-approved VASCADE vascular closure system. The VASCADE family of disposable devices is designed to deliver a resorbable collagen patch extravascularly to the arteriotomy site to facilitate hemostasis at the completion of a catheterization procedure. These devices are intended to assist physicians or catheter lab technicians in controlling bleeding from femoral arteriotomy sites and are intended to reduce time to hemostasis, time to ambulation, and time to discharge eligibility. The VASCADE catheter is introduced through the existing sheath at the completion of a catheterization procedure.

Meddevicetracker subscribers can access a full analysis of Cardiva's product portfolio, including the clinical and regulatory status of the VASCADE Vascular Closure System, here.

Not a subscriber? Click here to request your free demo.

Topics

UsernamePublicRestriction

Register

MT104594

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel